细胞解离市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会及预测 按类型、按产品类型、按组织、按最终用户、按地区细分

在 2024-2028 年的预测期内，全球细胞解离市场预计将以惊人的复合年增长率增长。这主要归因于生物制药行业研究的不断发展、个性化医疗需求的不断增长以及公共和政府对细胞研究投资的不断增加等因素。

传染病发病率上升

慢性疾病在人群中的流行率不断上升，推动了细胞分离技术的市场需求。传染病的日益流行是全世界人民关注的一个主要健康问题。例如，根据世界卫生组织（WHO）的数据，2019 年有 2.96 亿人感染慢性乙型肝炎，每年新增感染人数约 150 万。细胞解离在疾病诊断中有着非常重要的应用，因此在预测期内将促进全球细胞解离市场的增长。例如，细胞解离可分离出核酸、RNA 和 DNA，并进一步分析鉴定载体，进而鉴定疾病。对无细胞 DNA 进行测序可检测出丙型肝炎、艾滋病、乙型肝炎、巨细胞病毒和人类 T 细胞淋巴细胞病毒等传染性疾病。

癌症研究的资金和投资不断增加

肿瘤组织中的细胞种类繁多，需要多种基于细胞的分析技术来确定不同细胞亚型的特征。要对肿瘤组织进行进一步研究，需要先用蛋白水解酶将肿瘤组织解离成单细胞，然后使用涡旋或移液技术进行机械分解。微流体设备等技术可用于将消化后的组织集合体解离成单细胞。使用微流体设备可将细胞聚集体快速解离成单细胞，并获得完全存活的细胞。这种使用微流控装置的技术也可在无酶条件下使用。因此，这些方法有助于保护疑似肿瘤组织的单细胞检测和纯化方法，从而扩大研究范围，促进癌症生物学的发展，加强癌症检测中的分子诊断，从而支持预测期内的市场增长。

资金和投资的增加以及并购的增加

生命科学的多个领域对细胞解离的需求日益增长，其研究和治疗应用范围十分广泛。一些公司开始进行并购，以推动市场增长。例如，2021 年 3 月，罗氏诊断公司（Roche Diagnostics）宣布与 GenMark 诊断公司（GenMark Diagnostics Inc.通过此次收购，罗氏将获得 GenMark 的 ePlex 平台，该平台是一项尖端创新技术，只需一份患者样本就能检测多种疾病。这项技术的众多用途包括快速诊断细菌和病毒性疾病以及抗生素耐药性。此外，印度、中国、巴西等新兴经济体对生命科学研发的投资增加，也为市场需求提供了支持。例如，印度制药公司 Biocon 在 2020 年增加了研发投入，花费了 5879 万美元。

最新发展

2022 年，市场领先企业赛默飞世尔科技公司在马斯特里赫特举行的国际质谱会议上推出了专为高端生物制药和蛋白质组应用设计的 Orbitrap Ascend TriBrid 仪器。

可定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。报告可提供以下定制选项：

公司信息

• 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 市场覆盖范围
  • 研究年份
  • 主要市场细分

第 2 章：研究方法

• 研究目标
• 基准方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概述
• 主要市场细分概述
• 主要市场参与者概述
• 主要地区/国家概述
• 市场驱动因素、挑战和趋势概述

第4章：客户之声

第5章：全球细胞解离市场前景。

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（组织解离和细胞分离）
  • 按产品类型（酶解离产品、非酶解离产品以及仪器和配件）
  • 按组织（上皮组织、结缔组织及其他）
  • 按最终用户（生物技术公司、制药公司、学术研究机构及其他）
  • 按公司（2022 年）
  • 按地区
• 产品市场地图

第 6 章 : 亚太地区全球细胞解离市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 产品类型
  • 纸巾
  • 终端用户
  • 按国家
• 亚太地区：国家分析
  • 中国 .
  • 印度 .
  • 印度 .
  • 日本
  • 澳大利亚

第 7 章 : 欧洲全球细胞解离市场展望

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 产品类型
  • 纸巾
  • 终端用户 按国家分类
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章 : 北美洲全球细胞解离市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 产品类型
  • 纸巾
  • 终端用户
  • 按国家分类
• 北美洲：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 9 章：南美洲全球细胞解离市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 产品类型
  • 纸巾
  • 终端用户
  • 按国家分类
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲全球细胞解离市场展望

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 产品类型
  • 纸巾
  • 终端用户
  • 按国家
• 中东和非洲：国家分析
  • 南非 全球细胞解离
  • 沙特阿拉伯 全球细胞解离
  • 阿联酋 全球细胞分离
  • 科威特全球细胞分离

第 11 章 ：市场动态

• 驱动因素
• 挑战

第 12 章 ：市场趋势与发展

• 近期动态
• 合併与收购
• 产品开发

第 13 章 ：竞争格局

• 业务概述
• 公司概况
• 产品与服务
• 财务状况（上市公司）
• 近期发展
• SWOT 分析
  • BD Biosciences
  • Miltenyi Biotec
  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Group
  • Lonza
  • Danaher Corporation
  • Merck KGaA
  • STEMCELL Technologies
  • QIAGEN

第 14 章：战略建议

Global Cell Dissociation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research in biopharmaceutical industries, growing demand for personalized medicine, and rising public and governmental investments in cell-based research.

Cell dissociation is a significant step in several research applications, such as it is used in developing vaccines and in cell expansion.

Moreover, the rising development in advanced tissue dissociation, increased development & research studies in stem cell research, along with easy differentiation in enzyme-free dissociation products over the enzymatic dissociation products, etc., are factors that are supporting the market growth and are expected to propel it in the forecast period.

Rising Prevalence of Infectious Diseases

The growing prevalence of chronic diseases among the population is propelling the market demand for cell dissociation. The growing prevalence of infectious diseases is a major health concern among people around the world. For instance, according to the World Health Organization (WHO), 296 million people were affected with chronic hepatitis B infection in 2019, with around 1.5 million new infections developing each year. Cell dissociation founds a very significant application in disease diagnosis and thereby adds to the global cell dissociation market growth in the forecast period. For instance, cell dissociation leading to isolation of the nucleic acids, RNA and DNA, is further analyzed for identification of the vector and followed by the identification of the disease. Sequencing of cell-free DNA can result in the detection of infectious diseases such as hepatitis C, HIV, hepatitis B, cytomegalovirus, and human T-cell lymphotropic virus.

Increasing funding & investments for cancer research

Tumor tissues hold a distinct cell range, requiring several cell-based analysis techniques to characterize different cell subtypes. To undergo further research or study of the tumor tissue, it needs to be dissociated into single cells by undergoing treatments with proteolytic enzymes, which is followed by mechanical breakdown using vortexing or pipetting techniques. Techniques such as microfluidic devices are used for the dissociation of digested tissue aggregate into single cells. The microfluidic device usage results in the quick dissociation of cell aggregate into single cells and also results in obtaining cells in fully viable forms. This technique using microfluidic devices can also be used in enzyme-free conditions. These methods thus aid in the protection of single cell detection and purification methods for tumor-suspecting tissue and thereby enhancing the research scope for advancing cancer biology and enhancing molecular diagnosis in cancer detection, thereby supporting the market growth in the forecast period.

Increase in Funding & Investments Along with Rising Mergers & Acquisitions

There is a growing demand for cell dissociation in multiple fields of life sciences, having a wide range of research and therapeutic applications. Several companies have started mergers and acquisitions to propel the growth of the market. For instance, in March 2021, Roche Diagnostics, announced its partnership with GenMark Diagnostics Inc. Through the acquisition, Roche will have access to GenMark's ePlex platform, a cutting-edge innovation that enables testing for a variety of diseases using just one patient sample. Numerous uses of this technique include the quick diagnosis of bacterial and viral illnesses as well as antibiotic resistance. Additionally emerging economies such as India, China, Brazil, etc. are adding to support the market demand with increased rise in investment in research & development in life sciences. For instance, Indian pharmaceutical company Biocon increased investment and spent USD 58.79 million on research & development in 2020.

Recent Developments

In 2022, one of the leading market players, Thermo Fisher Scientific, at the international mass spectroscopy conference in Maastricht, launched the Orbitrap Ascend TriBrid instrument designed for high-end biopharma and proteomic applications.

Market Segmentation

Global Cell Dissociation Market is segmented based on the type, product type, tissue, end user, region, and competitive landscape. Based on the type, the market is further segmented into tissue dissociation & cell detachment. Based on the product type, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Based on tissue, the market is further fragmented into epithelial tissue, connective tissue, and others. Depending on the end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, and others. Based on the region, the Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

BD Biosciences, Miltenyi Biotec, Thermo Fisher Scientific, GE Healthcare, Sartorius Group, Lonza, Danaher Corporation, Merck KGaA, STEMCELL Technologies, and QIAGEN., etc.., are some of the major players operating in the Global Cell Dissociation Market.

Report Scope

In this report, Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Dissociation Market, By Type:

• Tissue Dissociation
• Cell Detachment

Cell Dissociation Market, By Product Type:

• Enzymatic Dissociation Products
• Non-Enzymatic Dissociation Products
• Instruments & Accessories

Cell Dissociation Market, By Tissue:

• Epithelial Tissue
• Connective Tissue
• Others

Cell Dissociation Market, By End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Academic and Research Institutes
• Others

Cell Dissociation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

• South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cell Dissociation Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Dissociation Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tissue Dissociation & Cell Detachment)
  • 5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
  • 5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
  • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
  • 5.2.5. By Company (2022)
  • 5.2.6. By Region
• 5.3. Product Market Map

6. Asia-Pacific Global Cell Dissociation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. Type
  • 6.2.2. Product Type
  • 6.2.3. Tissue
  • 6.2.4. End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Global Cell Dissociation Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. Type
      • 6.3.1.2.2. Product Type
      • 6.3.1.2.3. Tissue
      • 6.3.1.2.4. End user
  • 6.3.2. India Global Cell Dissociation Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. Type
      • 6.3.2.2.2. Product Type
      • 6.3.2.2.3. Tissue
      • 6.3.2.2.4. End user
  • 6.3.3. South Korea Global Cell Dissociation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. Type
      • 6.3.3.2.2. Product Type
      • 6.3.3.2.3. Tissue
      • 6.3.3.2.4. End user
  • 6.3.4. Japan Global Cell Dissociation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. Type
      • 6.3.4.2.2. Product Type
      • 6.3.4.2.3. Tissue
      • 6.3.4.2.4. End user
  • 6.3.5. Australia Global Cell Dissociation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. Polymer Type
      • 6.3.5.2.2. Application
      • 6.3.5.2.3. Tissue
      • 6.3.5.2.4. Technique

7. Europe Global Cell Dissociation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. Type
  • 7.2.2. Product Type
  • 7.2.3. Tissue
  • 7.2.4. End user By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Global Cell Dissociation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. Type
      • 7.3.1.2.2. Product Type
      • 7.3.1.2.3. Tissue
      • 7.3.1.2.4. End user
  • 7.3.2. Germany Global Cell Dissociation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. Type
      • 7.3.2.2.2. Product Type
      • 7.3.2.2.3. Tissue
      • 7.3.2.2.4. End user
  • 7.3.3. United Kingdom Global Cell Dissociation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. Type
      • 7.3.3.2.2. Product Type
      • 7.3.3.2.3. Tissue
      • 7.3.3.2.4. End user
  • 7.3.4. Italy Global Cell Dissociation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. Type
      • 7.3.4.2.2. Product Type
      • 7.3.4.2.3. Tissue
      • 7.3.4.2.4. End user
  • 7.3.5. Spain Global Cell Dissociation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. Type
      • 7.3.5.2.2. Product Type
      • 7.3.5.2.3. Tissue
      • 7.3.5.2.4. End user

8. North America Global Cell Dissociation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. Type
  • 8.2.2. Product Type
  • 8.2.3. Tissue
  • 8.2.4. End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Global Cell Dissociation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. Type
      • 8.3.1.2.2. Product Type
      • 8.3.1.2.3. Tissue
      • 8.3.1.2.4. End user
  • 8.3.2. Mexico Global Cell Dissociation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. Type
      • 8.3.2.2.2. Product Type
      • 8.3.2.2.3. Tissue
      • 8.3.2.2.4. End user
  • 8.3.3. Canada Global Cell Dissociation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. Type
      • 8.3.3.2.2. Product Type
      • 8.3.3.2.3. Tissue
      • 8.3.3.2.4. End user

9. South America Global Cell Dissociation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. Type
  • 9.2.2. Product Type
  • 9.2.3. Tissue
  • 9.2.4. End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Global Cell Dissociation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. Type
      • 9.3.1.2.2. Product Type
      • 9.3.1.2.3. Tissue
      • 9.3.1.2.4. End user
  • 9.3.2. Argentina Global Cell Dissociation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. Type
      • 9.3.2.2.2. Product Type
      • 9.3.2.2.3. Tissue
      • 9.3.2.2.4. End user
  • 9.3.3. Colombia Global Cell Dissociation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. Type
      • 9.3.3.2.2. Product Type
      • 9.3.3.2.3. Tissue
      • 9.3.3.2.4. End user

10. Middle East and Africa Global Cell Dissociation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. Type
  • 10.2.2. Product Type
  • 10.2.3. Tissue
  • 10.2.4. End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Global Cell Dissociation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. Type
      • 10.3.1.2.2. Product Type
      • 10.3.1.2.3. Tissue
      • 10.3.1.2.4. End user
  • 10.3.2. Saudi Arabia Global Cell Dissociation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. Type
      • 10.3.2.2.2. Product Type
      • 10.3.2.2.3. Tissue
      • 10.3.2.2.4. End user
  • 10.3.3. UAE Global Cell Dissociation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. Type
      • 10.3.3.2.2. Product Type
      • 10.3.3.2.3. Tissue
      • 10.3.3.2.4. End user
  • 10.3.4. Kuwait Global Cell Dissociation Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. Type
      • 10.3.4.2.2. Product Type
      • 10.3.4.2.3. Tissue
      • 10.3.4.2.4. End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Company Snapshot
• 13.3. Products & Services
• 13.4. Financials (In case of listed companies)
• 13.5. Recent Developments
• 13.6. SWOT Analysis
  • 13.6.1. BD Biosciences
  • 13.6.2. Miltenyi Biotec
  • 13.6.3. Thermo Fisher Scientific
  • 13.6.4. GE Healthcare
  • 13.6.5. Sartorius Group
  • 13.6.6. Lonza
  • 13.6.7. Danaher Corporation
  • 13.6.8. Merck KGaA
  • 13.6.9. STEMCELL Technologies
  • 13.6.10. QIAGEN

14. Strategic Recommendations